China pneumococcal polysaccharide vaccine market report, and market forecast

Pneumococcal disease is an infection caused by the bacterium Streptococcus pneumoniae, especially in infants and young children under 5 years of age.

According to the research on the market data of pneumococcal polysaccharide vaccine by Bergers Consulting, the global pneumococcal polysaccharide vaccine market size will reach 57.864 billion yuan (RMB) in 2023, and the market size of China's pneumococcal polysaccharide vaccine will reach x.x0 billion yuan. In view of the development trend of the pneumococcal polysaccharide vaccine market in the forecast year, Bergers Consulting predicts that the global pneumococcal polysaccharide vaccine market capacity will grow at a compound annual growth rate of 4.1% to reach 73.733 billion yuan in 2029.

Classified by product type, the pneumococcal polysaccharide vaccine industry can be subdivided into single-dose vials and prefilled syringes. In terms of terminal application, pneumococcal polysaccharide vaccine can be applied to children (2-10 years old), adults (10-64 years old), and the elderly (over 65 years old). The report analyzes the sales, growth rate, and market share of each segment in turn, with a focus on the dominant segments.

中国肺炎球菌多糖疫苗行业内主要厂商包括Astellas Pharma Inc, Glaxosmithkline Plc, Merck & Co, Inc, Pfizer Inc, Sanofi Pasteur, Serum Institute of India Pvt Ltd。报告分析了重点企业经营概况（涵盖肺炎球菌多糖疫苗销售量、销售收入、价格、毛利、毛利率等）、市场份额变化情况及肺炎球菌多糖疫苗行业前三大企业2023年的市场总份额。

Publisher: Hunan Beijiesi Information Consulting Co., Ltd

The major factors driving the growth of the pneumococcal polysaccharide vaccine market include: rising prevalence of pneumonia across the globe, improving healthcare infrastructure, government emphasis on pneumonia immunization programs, and development of high-quality vaccines such as PPSV23.

The report on China's pneumococcal polysaccharide vaccine industry expounds the market status of pneumococcal polysaccharide vaccine from multiple perspectives such as market capacity data, market segment share, brand competition pattern, industrial structure, market demand, regional market distribution, etc., and analyzes the historical development trend, industry status, future growth potential, and industry development opportunities of the pneumococcal polysaccharide vaccine market. The report not only has intuitive data charts, but also in-depth and scientific analysis, which is an important basis for enterprise users, universities and research institutes to fully understand the details of the industry, accurately grasp the market dynamics and make more accurate decisions.

The report also analyzes the competition pattern of the pneumococcal polysaccharide vaccine market, including the share of China's pneumococcal polysaccharide vaccine industry in the global market, the market share of CR3 and CR10 enterprises, and also studies the business operations of major enterprises in China, including the sales volume, sales, price, and profit of pneumococcal polysaccharide vaccine. Through visual analysis, the report helps target users accurately understand the current situation and industry environment of the pneumococcal polysaccharide vaccine market, grasp the market dynamics, and gain insight into the industry competition pattern.

Major Players:

Astellas Pharma Inc

Glaxosmithkline Plc

Merck & Co

Inc

Pfizer Inc

Sanofi Pasteur

Serum Institute of India Pvt Ltd

Product Categories:

Single-dose vials

Prefill syringes

Applications:

Child (2-10 years)

Adult (10-64 years)

Senior (over 65 years old)

In terms of research scope, the report includes research and analysis in key regions such as North China, Central China, South China, and East China, interprets the development status and policy trends of the pneumococcal polysaccharide vaccine industry in various regions, and involves various factors hindering the development of the pneumococcal polysaccharide vaccine industry in the region. Through this favorable information, industry enterprises, related companies and relevant departments can accurately grasp the development potential of the pneumococcal polysaccharide vaccine industry in different regions, determine the most potential market and adjust the layout.

The core contents of each chapter of the pneumococcal polysaccharide vaccine industry report:

Chapter 1: Pneumococcal polysaccharide vaccine industry overview, market size and industry development at home and abroad;

Chapter 2: Analysis of Industrial Competition Pattern, Concentration, and Ecological Layout of Domestic and Foreign Enterprises;

Chapter 3: Analysis of the import and export status, influencing factors, challenges and countermeasures of China's pneumococcal polysaccharide vaccine industry;

Chapter 4: Analysis of the development status and main policies of pneumococcal polysaccharide vaccine industry in North, Central, South and East China;

Chapters 5 & 6: Market Sales, Sales and Growth Rate of Pneumococcal Polysaccharide Vaccine by Subdivision Type and Pneumococcal Polysaccharide Vaccine in China by Application Segment;

Chapter 7: Analysis of the development overview, core business, market layout, operating conditions, market share changes, products and services, financing and cooperation dynamics of key enterprises in the pneumococcal polysaccharide vaccine industry;

Chapters 8 & 9: China Pneumococcal Polysaccharide Vaccine Market Volume, Sales and Growth Rate Forecast by Subdivision Type and Pneumococcal Polysaccharide Vaccine by Application Segment;

Chapter 10: Analysis of Macroeconomic Situation, Policy Trends and Foreseeable Risks;

Chapter 11 & 12: China Pneumococcal Polysaccharide Vaccine Market Size Forecast, Challenges and Opportunities, Problems and Development Suggestions.

China pneumococcal polysaccharide vaccine market report, and market forecast

Read on

China automotive tire and socks industry market research report

Chinese human-grade dog food industry market research report

This is the reason why the Chinese U17 men's basketball team lost to the United States, which turned out to be caused by these few things

Wimbledon first round: 5 members of the Chinese army advanced to tie the record, and Djokovic bloodied his opponent 3-0 to advance

Quick Facts丨Today's China Economic Times【July 3, 2024】

The Norwegian Ship King is in! Chinese shipyards take orders! This market is so hot!

The Indian guy asked the Chinese tourists: How many years will it take for you to have a motorcycle, and is 10 years enough?

Which countries can I go to for a self-driving trip with a Chinese driver's license? See where you want to go, if your driver's license works

U17 Men's World Cup: 中国遭立陶宛逆转惜败6min 张博源28+6郇斯楠伤退

The dawn of the Chinese men's basketball front: Zhang Boyuan set a new record with 28+6 and missed the quarterfinals, he became the only comfort

China U20 women's volleyball team 3-0 Australia locks Group A No. 1: The two opponents in the rematch are determined Sun Wanjun's progress is slow

British Foreign Secretary: In the past 10 years, China's diplomacy has been "aggressive" and no longer respects the West

The largest border city in China and the most unique city in Northeast China!

High blood pressure, high-risk groups, middle-aged and elderly people and healthy people should eat low sodium salt! Guidelines for the promotion of low sodium salts in China

Strongly support Chinese swimming, World Anti-Doping Agency President Banka, feared to be ousted by Europe and the United States!

The Indonesian Badminton Association announced the details of Zhang Zhijie's rescue, and Chinese netizens became even more angry after reading it!